Objective  To understand the perceptions and needs of target users of the public-facing diabetes knowledge platform, and to provide support and guidance for the construction and optimization of the platform.

Methods  Using convenience sampling and employing a descriptive qualitative research methodology, semi-structured individual interviews and focus group discussions were conducted with the platform's target users. Data analysis and thematic extraction were performed according to Colaizzi's seven-step analysis method.

Results  In-depth interviews were conducted with 27 participants, and four major themes were elicited: deficiencies in the diabetes platform, the design of platform functionalities, the frequency of platform updates, and the prospective role of the platform.

Conclusion  The study clarified that the platform should have the key functions of dynamic updating of recommendations and efficient and convenient retrieval. The construction of the platform will facilitate the dissemination and implementation of living guidelines, enhance the convenience of accessing recommendation, satisfy users’ information needs, promote the scientific and standardized approach to the diagnosis and treatment of diabetes. Moreover, it holds significant importance in improving the comprehensive level of diabetes management.

1.Poppas A, Elkind MSV, O'Gara PT, et al. Optimizing clinical practice guidelines: a key step to improving patient care and outcomes[J]. J Am Coll Cardiol, 2020, 76(18): 2170-2172.

2.靳英辉,王云云,高锦萍,等. 我国护理临床实践指南的质量评价[J]. 中国护理管理, 2020, 20(4): 506-512. [Jin YH, Wang YY, Gao JP, et al. Quality evaluation of nursing clinical practice guidelines in China[J]. Chinese Nursing Management, 2020, 20(4): 506-512.]

3.Neuman MD, Goldstein JN, Cirullo MA, et al. Durability of class I American College of Cardiology/American Heart Association clinical practice guideline recommendations[J]. JAMA, 2014, 311(20): 2092-100.

4.Jin Y, Li Z, Han F, et al. Barriers and enablers for the implementation of clinical practice guidelines in China: a mixed-method study[J]. BMJ Open, 2019, 9(9): e026328.

5.COVID 19 Recommendations. Recommendations map[EB/OL]. [2024-09-23]. https://covid19.recmap.org/grid

6.中华人民共和国国家卫生健康委员会. 成人糖尿病食养指南(2023年版)[J]. 全科医学临床与教育, 2023, 21(5): 388-391. [National Health Commission of the People's Republic of China. Dietary guidelines for adults with diabetes (2023 edition)[J]. Clinical Education of General Practice, 2023, 21(5): 388-391.]

7.International Diabetes Federation. Number of adults (20-79 years) withdiabetes inChina (CN)[EB/OL]. [2024-09-23]. https://diabetesatlas.org/data/en/country/42/cn.html

8.Luo Z, Fabre G, Rodwin VG. Meeting the challenge of diabetes in China[J]. Int J Health Policy Manag, 2020, 9(2):47-52.

9.Weller SC, Vickers B, Bernard HR, et al. Open-ended interview questions and saturation[J]. PLoS One, 2018, 13(6): e0198606.

10.Bayked EM, Kahissay MH, Workneh BD. Barriers and facilitators to insulin treatment: a phenomenological inquiry[J]. J Pharm Policy Pract, 2022, 15(1): 45.

11.刘明. Colaizzi七个步骤在现象学研究资料分析中的应用[J]. 护理学杂志, 2019, 34(11): 90-92. [Liu M. Using an example to illustrate Colaizzi's phenomenological data analysis method[J]. Journal of Nursing Science, 2019, 34(11): 90-92.]

12.Martínez García L, Sanabria AJ, García Alvarez E, et al. The validity of recommendations from clinical guidelines: a survival analysis[J]. CMAJ, 2014, 186(16): 1211-1219.

13.Akl EA, Meerpohl JJ, Elliott J, et al. Living systematic reviews: 4. living guideline recommendations[J]. J Clin Epidemiol, 2017, 91: 47-53.

14.张迁,王琪,后亮瑛,等. 动态指南制订方法及案例介绍[J]. 中国循证医学杂志, 2021, 21(4): 491-496. [Zhang Q, Wang Q, Hou LY, et al. An introduction to the development methods and cases of living guidelines[J]. Chinese Journal of Evidence-Based Medicine, 2021, 21(4): 491-496.]

15.Zhang Y, Liang S, Feng Y, et al. Automation of literature screening using machine learning in medical evidence synthesis: a diagnostic test accuracy systematic review protocol[J]. Syst Rev, 2022, 11(1): 11.

16.Fu M, Gong Z, Zhu Y, et al. Disparity in guideline-based antidiabetic drugs prescribing for type 2 diabetes patients in primary healthcare facilities across China, 2017-2019[J]. Pharmacoepidemiol Drug Saf, 2024, 33(8): e5882.

17.马旭,赵林华,马琳,等. 中国糖尿病防治相关指南基层推广现状分析[J]. 社区医学杂志, 2019, 17(19): 1167-1170. [Ma X, Zhao  LH, Ma L, et al. Current status of popularization and application of relevant guidelines for diabetes prevention and treatment in China at grass-roots level[J]. Journal of Community Medicine, 2019, 17(19): 1167-1170.]

18.田晨,王一芸,鲁佳乐,等. 麻醉专业医务人员临床实践指南实施现状调查与研究[J]. 临床麻醉学杂志, 2024, 40(5): 514-519. [Tian C, Wang YY, Lu JL, et al. Investigation and research of status on implementation of clinical practice guidelines by anesthesiologists[J]. Journal of Clinical Anesthesiology, 2024, 40(5): 514-519.]

19.黄超,李海龙,张川,等. 指南临床适用性评价实证研究:以糖尿病指南临床适用性评价为例[J]. 中国循证医学杂志, 2020, 20(5): 536-542. [Huang C, Li HL, Zhang C, et al. An empirical study on the evaluation of the clinical applicability of the guideline for diabetes[J]. Chinese Journal of Evidence-Based Medicine, 2020, 20(5): 536-542.]

20.王昕宇,李阳. 面向公众科普需求的应急救护知识服务平台构建与运行机制研究[J]. 现代情报, 2021, 41(12): 79-88. [Wang  XY, Li Y. Research on the construction and operation mechanism of the emergency care knowledge service platform oriented to the public demand for popular science[J]. Journal of Modern Information, 2021, 41(12): 79-88.]

21.Tian C, Xu M, Wang YY, et al. Barriers and strategies of clinical practice guideline implementation in China: aggregated analysis of 16 cross-sectional surveys[J]. J Public Health, 2024, 32: 1891-1904.